159 results
Page 2 of 8
S-4/A
vpbh2okp82un
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
425
EX-10.1
a36nh94y
19 May 23
Business combination disclosure
4:31pm
8-K
EX-10.1
9rhr1h9n7 j8l
19 May 23
Entry into a Material Definitive Agreement
4:31pm
425
EX-99.1
m61iyxjf
11 May 23
Business combination disclosure
5:04pm
8-K
EX-99.1
8dfo pqrcg
11 May 23
EIP Pharma to Present at JMP Securities Life Sciences Conference
5:04pm
S-4
EX-10.23
h2sbv
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
fwtfprogts5bld a0
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
awqc8zbf94is
3 Apr 23
Business combination disclosure
4:55pm
425
EX-2.1
fwj 5euz76c2
30 Mar 23
Business combination disclosure
8:51am
425
EX-99.2
3cl4y cy21pt
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-99.2
l7s jky03epjrpd7
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-2.1
71knc5t0i2qhn xz2ic
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
DEFA14A
17yex
16 Dec 22
Additional proxy soliciting materials
5:16pm
8-K
EX-99.1
u001387
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
PRRN14A
af1ebqq6r30a l3ie8
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFA14A
EX-99.1
jopstcoekwdt2
5 Dec 22
Additional proxy soliciting materials
9:59pm
8-K
EX-99.1
2003eb797x hs
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
DEFC14A
akk45d tzyp3h
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
vfkam78
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm